Editor's Note: Any reference to TheStreet Ratings and its underlying recommendation does not reflect the opinion of TheStreet, Inc. or any of its contributors including Jim Cramer or Stephanie Link. All three major indices are trading up today with the Dow Jones Industrial Average ( ^DJI) trading up 12 points (0.1%) at 14,943 as of Thursday, Sept. 5, 2013, 12:50 PM ET. The NYSE advances/declines ratio sits at 1,432 issues advancing vs. 1,453 declining with 120 unchanged. The Chemicals industry currently sits up 0.3% versus the S&P 500, which is up 0.2%. A company within the industry that fell today was Terra Nitrogen Company L.P ( TNH), up 2.6%. TheStreet would like to highlight 3 stocks pushing the industry lower today: 3. Agrium ( AGU) is one of the companies pushing the Chemicals industry lower today. As of noon trading, Agrium is down $0.73 (-0.9%) to $84.15 on light volume. Thus far, 230,980 shares of Agrium exchanged hands as compared to its average daily volume of 975,900 shares. The stock has ranged in price between $83.99-$85.18 after having opened the day at $85.18 as compared to the previous trading day's close of $84.88. Agrium Inc. engages in the retail of agricultural products and services. The company operates through three segments: Retail, Wholesale, and Advanced Technologies. Agrium has a market cap of $12.6 billion and is part of the basic materials sector. Shares are down 15.0% year to date as of the close of trading on Wednesday. Currently there are 12 analysts that rate Agrium a buy, 2 analysts rate it a sell, and 7 rate it a hold. TheStreet Ratings rates Agrium as a buy. The company's strengths can be seen in multiple areas, such as its revenue growth, largely solid financial position with reasonable debt levels by most measures and attractive valuation levels. We feel these strengths outweigh the fact that the company has had sub par growth in net income. Get the full Agrium Ratings Report now. STOCKS TO BUY: TheStreet Quant Ratings has identified a handful of stocks that can potentially TRIPLE in the next 12-months. Learn more.